(2021) showed that fibroblast growth factor 21 (FGF21) was associated with early, but not late stages of colon cancer, while pancreatic prohormone (PPY) was a promising biomarker for rectal cancer detection (20). This evidence concerns the gene FGF21 and rectal cancer.